CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹240 Cr | ₹1,547 Cr | ₹128 Cr | ₹128 Cr |
What is the latest Operating Profit of CORONA REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹240 Cr |
| Mar2025 | ₹1,547 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹128 Cr |
How is Operating Profit of CORONA REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹240 Cr | -84.49 | |
| Mar2025 | ₹1,547 Cr | 1,109.05 | |
| Mar2024 | ₹128 Cr | 0.00 | |
| Mar2023 | ₹128 Cr | - | |
Compare Operating Profit of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,611.2 Cr | -0.8% | -8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -0.8% |
-8% |
|
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses